Skip to content

A prospective cohort study conducted across multiple centers investigating pregnancy loss in China

A prospective cohort study conducted across multiple centers investigating pregnancy loss in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080514
Enrollment
Unknown
Registered
2024-01-31
Start date
2024-02-20
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy loss

Interventions

Case group:N/A
Control group:N/A

Sponsors

The Second hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Establishing prospective cohort studies, Exposure group: Women aged 18-45 who have lost at least one pregnancy. Non exposure group: at least one normal live birth in multiple centers, and no adverse pregnancies such as pregnancy loss have occurred (including intrauterine fetal death, stillbirth, fetal miscarriage, ectopic pregnancy, molar pregnancy, etc.), with no serious obstetric complications; No active autoimmune diseases within 3 months; Normal menstrual cycle; Age range from 18 to 45 years old.

Exclusion criteria

Exclusion criteria: The exclusion criteria for the exposed and non exposed groups in queue studies are consistent Have a history of taking anticoagulants, immunomodulators, and steroid drugs within the past 3 months; Patients who refuse to participate

Design outcomes

Primary

MeasureTime frame
24 weeks live birth rate;

Secondary

MeasureTime frame
Early pregnancy loss rate;Clinically confirmed pregnancy rate;Ongoing pregnancy rate(to 10 weeks);Ongoing pregnancy rate(to 12 weeks);28 weeks live birth rate;Ectopic pregnancy rate;Stillbirth rate;Incidence rate of pregnancy complications;Neonatal weigh;Neonatal Apgar score;Neonatal birth defect rate;

Countries

China

Contacts

Public ContactFang Wang

The Second hospital of Lanzhou University

ery_fwang@lzu.edu.cn+86 139 1930 2888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026